Nature of the Disclosure

Regulatory filing to BSE Limited regarding the outcome of a Postal Ballot conducted through remote e-voting by Kabra Drugs Limited (Scrip Code: 524322).

Key Quantitative Figures

Resolution 1 - Change in Name:

  • Votes in favor: 2,746,027 shares (99.85% of valid votes cast)
  • Votes against: 4,000 shares (0.15% of valid votes cast)
  • Total valid votes cast: 2,750,027 shares
  • Number of members voting in favor: 34
  • Number of members voting against: 1
  • Total members voting: 35

Resolution 2 - Alteration of Object Clause:

  • Votes in favor: 2,746,027 shares (99.85% of valid votes cast)
  • Votes against: 4,000 shares (0.15% of valid votes cast)
  • Total valid votes cast: 2,750,027 shares
  • Number of members voting in favor: 34
  • Number of members voting against: 1
  • Total members voting: 35

Dates of Action

  • Postal Ballot Notice date: 8th May 2026
  • Cut-off date for shareholder eligibility: 1st May 2026
  • Remote e-voting commencement: 12th May 2026 at 09:00 AM IST
  • Remote e-voting conclusion: 10th June 2026 at 05:00 PM IST
  • Resolution deemed passed: 10th June 2026
  • Scrutinizer's report date: 11th June 2026
  • Company disclosure date: 12th June 2026

Parties Involved

  • Stock Exchange: BSE Limited
  • Scrutinizer: CS Jay Arvind Jain, Proprietor of Jay Jain & Associates, Company Secretaries
  • E-voting service provider: CDSL
  • Company Director: Kuniamuthur Nanjappan Anand (DIN: 03230186)

Voting Process Details

The postal ballot was conducted through remote e-voting via CDSL. Shareholders holding shares as of the cut-off date (1st May 2026) were eligible to vote. The Notice and accompanying materials were sent only in electronic form to members who had registered their email IDs with depositories or with the Company. The e-voting module was disabled by CDSL after the voting period ended, and votes were unblocked in the presence of two witnesses not employed by the Company.

Outcome

Both special resolutions were approved with the requisite majority:

1. Change in name of the Company

2. Alteration (addition) of object clause of the Memorandum of Association

The resolutions are deemed to have been passed on 10th June 2026.

Financial Impact

Financial impact not quantified in the disclosure.

Capital Structure Impact

No direct impact on share capital or ownership structure disclosed. The voting rights were proportional to shareholders' paid-up equity share capital as of 1st May 2026.

#Tags: #KabraDrugs #PostalBallot #SEBIDisclosure #RegulatoryCompliance #CorporateRestructuring